Cargando…

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer

BACKGROUND: This study evaluated the effectiveness and safety of preoperative chemoradiotherapy with capecitabine in patients with locally advanced resectable rectal cancer. This report summarizes the results of the phase II study together with long-term (5-year) follow-up. METHODS: Between June 200...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velenik, Vaneja, Oblak, Irena, Anderluh, Franc
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955594/ https://www.ncbi.nlm.nih.gov/pubmed/20920276 http://dx.doi.org/10.1186/1748-717X-5-88

Ejemplares similares

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
por: Velenik, Vaneja, et al.
Publicado: (2011)

Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
por: Velenik, Vaneja, et al.
Publicado: (2012)

Long term outcome after combined modality treatment for anal cancer
por: Oblak, Irena, et al.
Publicado: (2012)

Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
por: Tuta, Mojca, et al.
Publicado: (2019)

Induction Chemotherapy, Chemoradiotherapy and Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer - Long-term Results of Phase II OIGIT-01 Trial
por: Golo, Danijela, et al.
Publicado: (2018)

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
por: Oblak, Irena, et al.
Publicado: (2013)

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
por: Oblak, Irena, et al.
Publicado: (2011)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
por: Ratosa, Ivica, et al.
Publicado: (2015)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
por: Perpar, Ana, et al.
Publicado: (2015)

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
por: Jeromen, Ana, et al.
Publicado: (2012)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
por: Tuta, Mojca, et al.
Publicado: (2021)

Preoperative Intensity-modulated Chemoradiation Therapy with Simultaneous Integrated Boost in Rectal Cancer: 2-year Follow-up Results of Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2018)

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
por: Oblak, Irena, et al.
Publicado: (2016)

Definitive Radiochemotherapy in Esophageal Cancer - A Single Institution Experience
por: Anderluh, Franc, et al.
Publicado: (2019)

Influence of Concurrent Capecitabine Based Chemoradiotherapy with Bevacizumab on The Survival Rate, Late Toxicity and Health-related Quality of Life in Locally Advanced Rectal Cancer: a Prospective Phase II CRAB Trial
por: Velenik, Vaneja, et al.
Publicado: (2020)

The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection
por: Grosek, Jan, et al.
Publicado: (2016)

Preoperative Intensity-modulated Chemoradiotherapy with Simultaneous Integrated Boost in Rectal Cancer: Five-year Follow-up Results of a Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2021)

Post-treatment surveillance in colorectal cancer
por: Velenik, Vaneja
Publicado: (2010)

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study
por: De Felice, Francesca, et al.
Publicado: (2018)

Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
por: Yu, Xin, et al.
Publicado: (2018)

Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer
por: Li, Zheng-Yan, et al.
Publicado: (2020)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: D’Alimonte, Lucrezia, et al.
Publicado: (2020)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Long-term outcomes of neoadjuvant-synchronous S-1 plus radiotherapy for locally advanced rectal cancer: a multi-institutional prospective phase II study
por: Hiratsuka, Takahiro, et al.
Publicado: (2018)

Short‐term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE‐1)
por: Kagawa, Yoshinori, et al.
Publicado: (2023)

Total neoadjuvant treatment in locally advanced rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2021)

Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study
por: Miki, Yoshitaka, et al.
Publicado: (2014)

Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial
por: Elwanis, Mostafa Abd, et al.
Publicado: (2009)

Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial
por: Nasrolahi, Hamid, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
por: Willeke, F, et al.
Publicado: (2007)

Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
por: Coraglio, Mariana F., et al.
Publicado: (2020)

Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study
por: Gural, Zeynep, et al.
Publicado: (2018)

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)
por: Glynne-Jones, R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bsuuvom06h188193upgiq7vueo